Acute circulatory effects of dopamine in patients with pulmonary hypertension.
AUTOR(ES)
Holloway, E L
RESUMO
Twenty-one patients, 11 with normal pulomonary artery pressures and 10 with pulmonary hypertension, had haemodynamic measurements performed before and during dopamine infusion while undergoing cardiac catheterization, in order to evaluate the circulatory effects of dopamine in pulmonary hypertension. In both groups on average, heart rate, pulmonary artery mean pressure, aortic mean pressure, and cardiac index increased significantly, while systemic vascular resistance fell significantly during dopamine administration. In neither group did the average pulmonary vascular resistance or right ventricular end-diastolic pressure change significantly. We conclude that dopamine is a safe and potentially useful drug for the treatment of reduced cardiac output, even in patients with pulmonary hypertension.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=482825Documentos Relacionados
- Detrimental effects of verapamil in patients with primary pulmonary hypertension.
- Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension.
- Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension.
- Cardiopulmonary function in patients with pulmonary hypertension.
- Impairment of endothelium-dependent pulmonary vasodilation in patients with primary pulmonary hypertension.
